Helen Sadri

New York University, Medical University of Vienna

Papers

3

Total Citations

183

H-Index

3

About

Helen Sadri is a leading urologic surgeon and researcher whose work has fundamentally shaped the surgical management of localized prostate cancer. Her research centers on comparative effectiveness, focusing on the clinical, oncologic, and functional outcomes of open, laparoscopic, and robot-assisted radical prostatectomy. Sadri’s landmark 2010 study, “Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience,” with over 130 citations, established a critical benchmark by systematically comparing these techniques across large international cohorts. She demonstrated that while minimally invasive approaches reduce blood loss, open radical prostatectomy remains the reference standard for oncologic control. Her subsequent work quantified the impact of intraoperative blood loss on complication rates and long-term functional recovery, providing surgeons with evidence-based parameters for patient counseling. Sadri also pioneered cost-effectiveness analyses, integrating economic considerations into surgical decision-making—a rare and vital contribution. Her studies are essential reading for any urology trainee or researcher evaluating the trade-offs between surgical approaches. Through rigorous comparative methodology, Sadri has helped define the modern standard of care for prostate cancer surgery.

Research Focus

Key Achievements

3
H-Index
3
Papers
183
Total Citations
61
Avg Citations/Paper
🏆 Most Cited Paper
Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience.
132 citations · 2010
📈 Most Prolific Year: 2010 (2 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: New York University, Medical University of Vienna

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago